Sfoglia per Autore
Plasma adiponectin in non alcoholic fatty liver disease is related to hepatic insulin resistance and hepatic fat content
2005-01-01 E. Vanni; E. Bugianesi; U. Pagotto; E. Gentilcore; R. Manini; A. Gastaldelli; S. Natale; G. Marchesini; M. Rizzetto
Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity
2005-01-01 E. Bugianesi; U. Pagotto; R. Manini; E. Vanni; A. Gastaldelli; R. de Iasio; E. Gentilcore; S. Natale; M. Cassader; M. Rizzetto; R. Pasquali; G. Marchesini
A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease
2005-01-01 E. BUGIANESI; E. GENTILCORE; R. MANINI; S. NATALE; E. VANNI; N. VILLANOVA; E. DAVID; M. RIZZETTO; G. MARCHESINI
Different contribution of metabolic and viral steatosis to liver damage
2005-01-01 E. Bugianesi; G. Marchesini; E. Gentilcore; I.H.Y Cua; E. Vanni; M. Rizzetto; J. George
Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis
2006-01-01 E. BUGIANESI; G. MARCHESINI; E. GENTILCORE; I.H.Y. CUA; E. VANNI; M. RIZZETTO; J. GEORGE
Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia; evidence from a case control study
2007-01-01 L. Valenti;A.L. Fracanzani;P. Dongiovanni;E. Bugianesi;E. Vanni;G. Marches;S. Fargion
Intrauterine growth retardation, insulin resistance, and nonalcoholic fatty liver disease in children
2007-01-01 V. Nobili; M. Marcellini; G. Marchesini; E. Vanni; M. Manco; A. Villani; E. Bugianesi
Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study
2007-01-01 VALENTI L; FRACANZANI AL; DONGIOVANNI P; BUGIANESI E; MARCHESINI G; MANZINI P; VANNI E; FARGION S
NASH and the risk of cirrhosis and hepatocellular carcinoma in type 2 diabetes
2007-01-01 E. Bugianesi;E. Vanni;G. Marchesini
Metabolic significance of hepatic steatosis in non alcoholic fatty liver disease and chronic hepatitis C.
2008-01-01 E. Bugianesi; E. Vanni; E. Gentilcore; M. Rizzetto; R. Gambino; M. Cassader; G. Pagano; A. Gastaldelli; D. Ciociaro; E. Ferrannini
Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes
2008-01-01 Fracanzani AL; Valenti L; Bugianesi E; Andreoletti M; Colli A; Vanni E; Bertelli C; Fatta E; Bignamini D; Marchesini G; Fargion S.
A comparative study between ultrasound evaluation, liver stiffness measurement and biopsy for staging of hepatic fibrosis in patients with chronic liver disease
2009-01-01 S. Gaia; C. Cocuzza; E. Rolle; E. Bugianesi; P. Carucci; E. Vanni; A. Evangelista; M. Rizzetto; F. Brunello
PNPLA3/adiponutrin genotype is strongly associated with metabolic syndrome components and liver damage in patients with Nonalcoholic Fatty Liver Disease
2009-01-01 L. Valenti; E. Galmozzi; P. Dongiovanni; R. Rametta; E. Lattuada; M. Zappa; E. Mozzi; G. Roviaro; M. Maggioni; E. Vanni; E. Bugianesi; A. L. Fracanzani; S. Fargion
Increased liver expression of inflammatory mediators is associated with hepatic insulin resistance in lean, non-diabetic CHC patients.
2009-01-01 E. Vanni; M.L. Abate; E. Gentilcore; C. Elia; R. Gambino; M. Cassader; A. Smedile; M. Rizzetto; G. Marchesini; A. Gastaldelli; E. Bugianesi.
Sites and mechanisms of insulin resistance in nonobese, nondiabetic patients with chronic hepatitis C
2009-01-01 Vanni E; Abate ML; Gentilcore E; Hickman I; Gambino R; Cassader M; Smedile A; Ferrannini E; Rizzetto M; Marchesini G; Gastaldelli A; Bugianesi E.
Risk of NASH and severe fibrosis in patients with NAFLD and low visceral adiposity
2009-01-01 A.L. Fracanzani; L. Valenti; E. Bugianesi; E. Vanni; L. Miele; C. Bertelli; E. Fatta; A. Grieco; G. Marchesini; S. Fargion
The gut-liver axis in nonalcoholic fatty liver disease: Another pathway to insulin resistance?
2009-01-01 Vanni E; Bugianesi E.
Increased liver expression of inflammatory mediators is associated with hepatic insulin resistance in lean, non-diabetic patients with chronic hepatitis C.
2009-01-01 E. Vanni; M.L. Abate; E. Gentilcore; C. Elia; R. Gambino; M. Cassader; A. Smedile; M. Rizzetto; G. Marchesini; A. Gastaldelli; E. Bugianesi.
Homozygosity for the PNPLA3/adiponutrin I148M polymorphism influences liver fibrosis in patients with Nonalcoholic Fatty Liver Disease
2010-01-01 L. Valenti; A. Al-Serri; A.K. Daly; E. Galmozzi; R. Rametta; P. Dongiovanni; V. Nobili; E. Mozzi; G. Roviaro; E. Vanni; E. Bugianesi; M. Maggioni; A.L. Fracanzani; S. Fargion; C.P. Day
Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease.
2010-01-01 Valenti L; Al-Serri A; Daly AK; Galmozzi E; Rametta R; Dongiovanni P; Nobili V; Mozzi E; Roviaro G; Vanni E; Bugianesi E; Maggioni M; Fracanzani AL; Fargion S; Day CP.
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile